The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma

Noriko Himori,1 Maki Inoue Yanagimachi,1 Kazuko Omodaka,1,2 Yukihiro Shiga,1 Satoru Tsuda,1 Hiroshi Kunikata,1,3 Toru Nakazawa1– 4 1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Department of Ophthalmic Imaging and Information Analytics, Tohoku...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Himori N, Inoue Yanagimachi M, Omodaka K, Shiga Y, Tsuda S, Kunikata H, Nakazawa T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/1f20354f97d546908132ebb0e55468d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f20354f97d546908132ebb0e55468d2
record_format dspace
spelling oai:doaj.org-article:1f20354f97d546908132ebb0e55468d22021-12-02T18:05:05ZThe Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma1177-5483https://doaj.org/article/1f20354f97d546908132ebb0e55468d22021-06-01T00:00:00Zhttps://www.dovepress.com/the-effect-of-dietary-antioxidant-supplementation-in-patients-with-gla-peer-reviewed-fulltext-article-OPTHhttps://doaj.org/toc/1177-5483Noriko Himori,1 Maki Inoue Yanagimachi,1 Kazuko Omodaka,1,2 Yukihiro Shiga,1 Satoru Tsuda,1 Hiroshi Kunikata,1,3 Toru Nakazawa1– 4 1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Japan; 3Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, Japan; 4Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, JapanCorrespondence: Toru NakazawaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-cho Aoba-ku, Sendai, Miyagi, 980-8574, JapanTel +81-22-717-7294Fax +81-22-717-7298Email ntoru@oph.med.tohoku.ac.jpPurpose: Oxidative stress may be a risk factor for glaucoma, and many previous reports have suggested that antioxidants could be a promising treatment. Here, we investigated the effects of a novel supplement containing three food-derived antioxidants (hesperidin, crocetin, and Tamarindus indica) on markers of oxidative stress in patients with glaucoma.Patients and Methods: This study had a prospective, single arm design. Thirty Japanese glaucoma patients were recruited and given 4 tablets with ample water twice a day for 8 weeks. The treatment was stopped, and the subjects were followed for an additional 8 weeks. We measured biological antioxidant potential (BAP) with a free radical analyzer. We also measured urinary 8-hydroxy-2ʹ-deoxyguanosine (8-OHdG; a marker of oxidative DNA damage). Clinical laboratory data were measured in venous blood samples. Clinical parameters were also recorded. Comparisons used a one-way analysis of variance (ANOVA) followed by Dunnett’s test.Results: The 8-OHdG level was not reduced. We also divided the patients into groups with high or low oxidative stress. In patients with relatively high oxidative stress, the 8-OHdG level was significantly reduced at weeks 4, 8, 12, and 16 (P < 0.001, P < 0.01, P < 0.01, P < 0.01), and BAP was significantly elevated at weeks 8 and 12 (P = 0.03, P = 0.04). In patients with relatively low oxidative stress, the 8-OHdG level was not significantly reduced during supplement intake but was significantly elevated at weeks 12 and 16 (P =0.03, P = 0.04), while BAP was not significantly elevated.Conclusion: An 8-week oral course of antioxidant supplementation was effective in patients with a high oxidative stress level. Dietary supplementation could hold promise in the treatment of systemic oxidative stress-related diseases.Keywords: oxidative stress, supplement, glaucoma, 8-OHdGHimori NInoue Yanagimachi MOmodaka KShiga YTsuda SKunikata HNakazawa TDove Medical Pressarticleoxidative stresssupplementglaucoma8-ohdgOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 2293-2300 (2021)
institution DOAJ
collection DOAJ
language EN
topic oxidative stress
supplement
glaucoma
8-ohdg
Ophthalmology
RE1-994
spellingShingle oxidative stress
supplement
glaucoma
8-ohdg
Ophthalmology
RE1-994
Himori N
Inoue Yanagimachi M
Omodaka K
Shiga Y
Tsuda S
Kunikata H
Nakazawa T
The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
description Noriko Himori,1 Maki Inoue Yanagimachi,1 Kazuko Omodaka,1,2 Yukihiro Shiga,1 Satoru Tsuda,1 Hiroshi Kunikata,1,3 Toru Nakazawa1– 4 1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Japan; 3Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, Japan; 4Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, JapanCorrespondence: Toru NakazawaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-cho Aoba-ku, Sendai, Miyagi, 980-8574, JapanTel +81-22-717-7294Fax +81-22-717-7298Email ntoru@oph.med.tohoku.ac.jpPurpose: Oxidative stress may be a risk factor for glaucoma, and many previous reports have suggested that antioxidants could be a promising treatment. Here, we investigated the effects of a novel supplement containing three food-derived antioxidants (hesperidin, crocetin, and Tamarindus indica) on markers of oxidative stress in patients with glaucoma.Patients and Methods: This study had a prospective, single arm design. Thirty Japanese glaucoma patients were recruited and given 4 tablets with ample water twice a day for 8 weeks. The treatment was stopped, and the subjects were followed for an additional 8 weeks. We measured biological antioxidant potential (BAP) with a free radical analyzer. We also measured urinary 8-hydroxy-2ʹ-deoxyguanosine (8-OHdG; a marker of oxidative DNA damage). Clinical laboratory data were measured in venous blood samples. Clinical parameters were also recorded. Comparisons used a one-way analysis of variance (ANOVA) followed by Dunnett’s test.Results: The 8-OHdG level was not reduced. We also divided the patients into groups with high or low oxidative stress. In patients with relatively high oxidative stress, the 8-OHdG level was significantly reduced at weeks 4, 8, 12, and 16 (P < 0.001, P < 0.01, P < 0.01, P < 0.01), and BAP was significantly elevated at weeks 8 and 12 (P = 0.03, P = 0.04). In patients with relatively low oxidative stress, the 8-OHdG level was not significantly reduced during supplement intake but was significantly elevated at weeks 12 and 16 (P =0.03, P = 0.04), while BAP was not significantly elevated.Conclusion: An 8-week oral course of antioxidant supplementation was effective in patients with a high oxidative stress level. Dietary supplementation could hold promise in the treatment of systemic oxidative stress-related diseases.Keywords: oxidative stress, supplement, glaucoma, 8-OHdG
format article
author Himori N
Inoue Yanagimachi M
Omodaka K
Shiga Y
Tsuda S
Kunikata H
Nakazawa T
author_facet Himori N
Inoue Yanagimachi M
Omodaka K
Shiga Y
Tsuda S
Kunikata H
Nakazawa T
author_sort Himori N
title The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
title_short The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
title_full The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
title_fullStr The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
title_full_unstemmed The Effect of Dietary Antioxidant Supplementation in Patients with Glaucoma
title_sort effect of dietary antioxidant supplementation in patients with glaucoma
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/1f20354f97d546908132ebb0e55468d2
work_keys_str_mv AT himorin theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT inoueyanagimachim theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT omodakak theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT shigay theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT tsudas theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT kunikatah theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT nakazawat theeffectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT himorin effectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT inoueyanagimachim effectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT omodakak effectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT shigay effectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT tsudas effectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT kunikatah effectofdietaryantioxidantsupplementationinpatientswithglaucoma
AT nakazawat effectofdietaryantioxidantsupplementationinpatientswithglaucoma
_version_ 1718378675844415488